Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2008
08/13/2008EP1200103B1 XENON AS NMDA ANTAGONIST for neuroprotection
08/13/2008EP0669987B1 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain
08/13/2008EP0647137B1 Glycine receptor antagonists and the use thereof
08/13/2008CN201097861Y Chinese medicine health care mattress
08/13/2008CN101243091A Tricyclic compounds useful as 5-serotonin inhibitors and 5-HT1A agonists and antagonists
08/13/2008CN101243089A Halogenated pyrazolo [1,5-A]pyrimidines, processes, uses as GABA-A receptors ligand, compositions and intermediates
08/13/2008CN101243083A Naphthyridine compounds
08/13/2008CN101243082A Hexahydro-pyrrolo-isoquinoline compounds for the treatment of CNS disorders
08/13/2008CN101243079A Tricyclic opioid modulators
08/13/2008CN101243078A Thiazolyl piperidine derivatives useful as h3 receptor modulators
08/13/2008CN101243077A New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions
08/13/2008CN101243076A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101243075A Novel 2,3-dihydroindole compounds
08/13/2008CN101243051A P38 MAP kinase inhibitors and methods for using the same
08/13/2008CN101243045A New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
08/13/2008CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101242823A Composition comprising oleic acid and the use thereof
08/13/2008CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
08/13/2008CN101239983A Chiral synthesis method for (-)-galantamin hydrobromide
08/13/2008CN101239981A Pyrazolo and imidazo-pyrimidine derivatives
08/13/2008CN101239157A Chinese herbal medicine oral liquid formulations (bamboo juice five Zang-organs sedative liquid) for treating pathogenic heat toxic type mad diseases
08/13/2008CN101239137A Natural medicinal formulations for treating senile dementia and cerebral infarction and preparation thereof
08/13/2008CN101239129A Method for preparing Chinese medicine with qi-benefitting and detoxication, blood seasis-dispersing and detumescence, and stomach-regulating and sedative function
08/13/2008CN101239124A Chinese medicinal composition for treating aypnia
08/13/2008CN101239118A Composition comprising panax ginseng and paulliniacupana extracts
08/13/2008CN101239104A Kava piper methysticum extract and manufacturing method thereof
08/13/2008CN101239088A Medicinal composition containing caffeine
08/13/2008CN101239078A Placenta immunoregulation medicament capsule
08/13/2008CN101239076A Blood plasma immunoregulation medicament capsule
08/13/2008CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances
08/13/2008CN101239059A Use of levetiracetam in preparing intelligence-benefiting medicaments
08/13/2008CN101239057A Use of salvianolic acid B and its salt in treating parkinson's disease
08/13/2008CN101239049A Hypnotic drugs zaleplon dispersible tablet and preparation thereof
08/13/2008CN101238894A Health food with sleep-improving function and its preparation
08/13/2008CN100410265C Gastrodine derivative, its preparation method, pharmaceutical composition and uses
08/13/2008CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
08/13/2008CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
08/13/2008CN100409896C Senile dementia vaccinum and preparing method thereof
08/13/2008CN100409889C Abstinence wine
08/13/2008CN100409883C Chinese medicinal composition for treating agrypnia, functional gastricism and astriction and its preparation method
08/13/2008CN100409867C Capsule for calming the wind and stopping twitching
08/13/2008CN100409858C Composition of luffa seed oil
08/13/2008CN100409850C Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain
08/13/2008CN100409848C Stable injection solution of freeze drying powder of lappaconite hydrobromide and preparation method thereof
08/13/2008CN100409847C Transdermal delivery system for alkaloids of aconitum species
08/13/2008CN100409768C Health-caring, low cholesterol egg with antioxidant, presenile dementia preventing functions
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy
08/12/2008US7411055 Genetic engineering
08/12/2008US7411043 Slo4 potassium channel proteins
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7411004 Sulphones which modulate the action of gamma secretase
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/12/2008US7410996 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
08/12/2008US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders
08/12/2008US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause
08/12/2008US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors
08/12/2008US7410987 Treating pruritus or pain, particularly that caused by a rheumatic disease, by administering a 2-[o-(aminoalkoxy)phenyl])-3-acylbenzothiazoline, e.g., 3-Acetyl-6-chloro-2-[2-(3-(N-(2-hydroxyethyl)-N-isopropylamino)-propoxy)-5-methoxyphenyl]benzothiazoline
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410982 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride
08/12/2008US7410973 4-amino-substituted pyrimidine derivatives
08/12/2008US7410955 Therapeutic use of agonist ligands specific to G2A receptor
08/12/2008US7410759 Compositions and methods for diagnosing and treating mood disorders
08/12/2008US7410757 Expressing nucleic acid in tissue from occipital cortex of brain showing cell death as result of Alzheimer's Disease; isolating suppressor gene
08/12/2008US7410652 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410651 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410642 Assays and therapies for latent viral infection
08/12/2008US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders
08/12/2008CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
08/12/2008CA2396156C Osmotic device containing venlafaxine and an anti-psychotic agent
08/12/2008CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity
08/12/2008CA2320224C Method for modulating macrophage activation
08/12/2008CA2304568C Olanzapine pamoate formulations
08/12/2008CA2217590C Use of imidazo[1,2-a]pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with dysfunction of the neural circuits of the basal ganglia
08/07/2008WO2008094571A1 Methods for treating acute and subchronic pain
08/07/2008WO2008094476A1 Substituted pyrano [2, 3 - b] pyridine derivatives as cannabinoid -1 receptor modulators
08/07/2008WO2008094473A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/07/2008WO2008094222A2 Porphyrin catalysts and methods of use thereof
08/07/2008WO2008094053A1 Dosage regimen for comt inhibitors
08/07/2008WO2008093919A1 Use of n-benzyl-n-(2-dimethylamino-ethyl)benzenesulfonamide derivatives for treating central nervous system disorders
08/07/2008WO2008093827A1 Therapeutic agent for central nervous system disorder, and method for treatment of central nervous system disorder
08/07/2008WO2008093825A1 Caffeine analog
08/07/2008WO2008093763A1 Agent for activating or improving neuronal cell or brain function
08/07/2008WO2008093737A1 Amide derivative
08/07/2008WO2008093709A1 Composition for prevention or treatment of disease associated with amyloidosis through inhibition of aggregation amyloid protein and through promotion of degradation of amyloid protein
08/07/2008WO2008093691A1 Protective agent for retinal nerve or optic nerve
08/07/2008WO2008093646A1 Peptide capable of activating wnt signaling
08/07/2008WO2008093495A1 Agent for treatment of multiple sclerosis
08/07/2008WO2008093360A2 A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride
08/07/2008WO2008093236A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/07/2008WO2008093227A1 Tricyclic compounds and their use as glucocorticoid receptor modulators
08/07/2008WO2008093142A1 Process for the preparation of o-desmethyl venlafaxine
08/07/2008WO2008092898A1 Treatment of protein aggregation diseases
08/07/2008WO2008092891A1 1-oxa-3-azaspiro(4.5)decan-2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092888A1 1-oxa-3-azaspiro[4,5]decan--2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092887A1 I-oxa-3-azaspiro (4.5) decan-2-one and 1-oxa-3, 8-diazaspiro (4.5) decan-2-one derivatives for the treatment of eating disorders
08/07/2008WO2008092881A1 New crystal form of cabergoline
08/07/2008WO2008092879A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092878A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
08/07/2008WO2008092877A2 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
1 ... 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 ... 1833